Recent Activity

Loading...

DNA

Ginkgo Bioworks Holdings, Inc. Class A · NYSE

Performance

-5.64%

1W

-13.52%

1M

-27.6%

3M

-38.55%

6M

-44.73%

YTD

-31.82%

1Y

Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Investment Analysis Report: DNA

Overview

In this investment analysis report, we will delve into a comprehensive evaluation of DNA, a company operating in the Health Services sector within the Medical/Nursing Services industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ...

See more ...

Technical Analysis of DNA 2024-05-03

Overview:

In analyzing the technical indicators for DNA stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and make informed prediction...

See more ...

Recent News & Updates